639.6000 17.10 (2.75%)
NSE Mar 28, 2025 15:31 PM
Volume: 906.4K
 

ICICI Securities Limited
Krishna Institute of Medical Sciences’ (KIMS) Q3FY25 revenue was in-line while EBITDA and PAT were dragged by seasonality and its new Nashik hospitals. KIMS’ hospitals in Telangana/Andhra Pradesh grew a robust 26.1%/27.8% YoY. In Q3FY25, it commenced operations at its 325-bed hospital in Nashik (EBITDA loss of INR 50mn in Q3FY25), which is likely to break even by Q3FY26.
Number of FII/FPI investors increased from 195 to 206 in Dec 2024 qtr.
More from Krishna Institute of Medical Sciences Ltd.
Recommended